Data as of Apr 17
| -0.01 / -1.92%|
Cardium Therapeutics, Inc. is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses having the potential to address significant unmet medical needs, and definable pathways to commercialization, partnering and other economic monetization. It operates through two segments: Pharmaceutical Products and Nutraceutical Products: The Pharmaceutical segment engages in the development, testing and clinical trials of Generx and Excellagen products. The Nutraceutical segment engages in the purchasing, packaging, selling and distribution of the To Go Brands portfolio of products. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde on December 22, 2003 and is headquartered in San Diego, CA.
|Christopher J. Reinhard||Chairman, President, CEO & Treasurer|
|Dennis M. Mulroy||Chief Financial Officer|
|Ted Williams||VP-Manufacturing & Technical Operations|
|Gabor M. Rubanyi||Chief Scientific Officer|
|Tyle M. Dylan-Hyde||Secretary, Director, Chief Business Officer & EVP|